Fundraising Fox

HotSpot Therapeutics

7 known investors

hotspotthera.com ↗

HotSpot Therapeutics is a drug discovery company developing small-molecule allosteric medicines by targeting "natural hotspots" — regulatory on/off switches on proteins. Its Smart Allostery platform combines structure-function analysis, pharmacology, chemistry, and AI to discover treatments for autoimmune diseases.

AI & Machine LearningBiotechHealthtech

Investors · 7

Atlas VentureCambridge · $500K – $1M
B Capital GroupManhattan Beach · $10M – $50M
B4 Capital$10M – $50M
MRL Ventures FundCambridge · $25M
Sofinnova PartnersParis · $540K – $27M
Solasta VenturesBoston
SR One Capital ManagementRedwood City

Competitors · 1

by search overlap
Fiveable8 shared keywordsFiveable provides AI-powered exam preparation for AP classes, offering practice questions with automated scoring and personalized study tools for high school students.

Companies competing with HotSpot Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic - HotSpot Therapeuticshotspotthera.com · Nov 2021HotSpot Therapeutics Raises $100M in Series C Fundingfinsmes.com · Nov 2021HotSpot Therapeutics Raises $65 Million - Global Genesglobalgenes.org · May 2020HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicinesprnewswire.com · May 2020

Frequently asked questions

What does HotSpot Therapeutics do?
HotSpot Therapeutics is a drug discovery company developing small-molecule allosteric medicines by targeting "natural hotspots" — regulatory on/off switches on proteins. Its Smart Allostery platform combines structure-function analysis, pharmacology, chemistry, and AI to discover treatments for autoimmune diseases.
Who are HotSpot Therapeutics's investors?
HotSpot Therapeutics's investors include Atlas Venture, B Capital Group, B4 Capital, MRL Ventures Fund, Sofinnova Partners, Solasta Ventures, SR One Capital Management.